Research

For May 2021, we have selected: Walgaard et al. Second intravenous immunoglobulin dose in patients with Guillain-Barré syndrome with poor prognosis (SID-GBS): a double-blind, randomised, placebo-controlled trial. Lancet Neurol 2021; 20=:275-283. doi: 10.1016/S1474-4422(20)30494-4.

For June 2021, we have selected the following paper: Dagan N. et al. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. N Engl J Med 2021; 384:1412-1423. doi: 10.1056/NEJMoa2101765.

Two patients with severe PML have been successfully treated with BK virus-specific T cells at Hannover Medical School's Department of Neurology, according to director, Prof. Günter Höglinger.

Archeological neuroimmunology- pathogenic immune response from a case of more than 60 years ago characterized from archival brain tissue

Anticoagulation Therapy in Patients With Coronavirus Disease 2019: Results From a Multicenter International Prospective Registry (Health Outcome Predictive Evaluation for Corona Virus Disease 2019 [HOPE-COVID19])

Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial

COVID-19 dynamics after a national immunization program in Israel

Obstructive sleep apnea (OSA) and outcomes from coronavirus disease 2019 (COVID-19) pneumonia: a systematic review and meta-analysis

Serum neurofilament light chain (sNfL) values in a large cross-sectional population of children with asymptomatic to moderate COVID-19

Cerebral Venous Thrombosis in COVID-19: A New York Metropolitan Cohort Study

Neurosensory dysphagia in a COVID-19 patient

SARS-CoV-2 and Stroke Characteristics: A Report From the Multinational COVID-19 Stroke Study Group

Hypothyroidism is associated with prolonged COVID-19-induced anosmia: a case-control study

Transcranial Doppler in Acute COVID-19 Infection: Unexpected Associations

Dementia is an age-independent risk factor for severity and death in COVID-19 inpatients